Company Update: Celgene Corporation (NASDAQ:CELG) – Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013

[at Motley Fool] – Mantle cell lymphoma patients got new hope this year from newly approved drugs from Johnson (JNJ), Pharmacyclics (PCYC) and Celgene (CELG). But that hope comes at a steep price. . . . → Read More: Company Update: Celgene Corporation (NASDAQ:CELG) – Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013 Similar posts: Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Participate in Credit Suisse 2013 Health Care Conference 2013 Biotech Watchlist Update: Companies Climb and Crumble on Catalysts Stop the insanity and bring back Glass-Steagall!